Literature DB >> 24402457

Incidence and risk factors for injuries to the recurrent laryngeal nerve during neck surgery in the moderate-volume setting.

Kalle Landerholm1, Anna-Maria Wasner, Johannes Järhult.   

Abstract

PURPOSE: Total lobectomy is currently recommended also in benign thyroid disease in order to reduce the risk of goitre recurrence, an approach claimed not to increase post-operative morbidity. The aim of the study was to analyse risk factors for recurrent laryngeal nerve (RLN) palsy during neck surgery, with particular interest in complications after total lobectomy and subtotal resection, respectively.
METHODS: All consecutive patients operated for thyroid and parathyroid diseases at one institution between 1984 and 2011 were prospectively recorded, and 1,322 patients were included. Patients with permanent post-operative RLN palsy were re-examined in 2011.
RESULTS: The risk of permanent RLN palsy after parathyroid surgery was 0.3 %. Patients operated for thyroid cancer had a 5.9 % risk of permanent nerve injury, higher than that of patients with benign thyroid disease (1.4 %; P = 0.029). Independent risk factors for RLN paralysis after benign thyroid surgery were intrathoracic goitre (odds ratio (OR), 3.57; 95 % confidence interval, 1.70-7.48), ipsilateral redo-surgery (OR, 3.64; 1.00-13.28) and total lobectomy (OR, 2.41; 1.05-5.55). At long-time follow-up (median, 10 years), 7 of 12 patients with permanent RLN palsy still suffered moderate or severe symptoms.
CONCLUSIONS: RLN paralysis is an infrequent complication after neck surgery, but with major negative impact on patients' well-being when permanent. Hemithyroidectomy/total thyroidectomy is increasingly preferred over subtotal resection in multinodular goitre. This is supported by an increased risk of RLN injury during redo-surgery for recurrency but should be carefully weighed against individual risk factors for nerve palsy, including surgical experience and volume.

Entities:  

Mesh:

Year:  2014        PMID: 24402457     DOI: 10.1007/s00423-013-1154-6

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  39 in total

1.  Thyroid surgery and the recurrent laryngeal nerve.

Authors:  M H Wheeler
Journal:  Br J Surg       Date:  1999-03       Impact factor: 6.939

2.  Total thyroidectomy: the evolution of surgical technique.

Authors:  Leigh Delbridge
Journal:  ANZ J Surg       Date:  2003-09       Impact factor: 1.872

3.  Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients.

Authors:  A Bergenfelz; S Jansson; A Kristoffersson; H Mårtensson; E Reihnér; G Wallin; I Lausen
Journal:  Langenbecks Arch Surg       Date:  2008-07-17       Impact factor: 3.445

4.  Morbidity following thyroid surgery: does surgeon volume matter?

Authors:  Carmen González-Sánchez; Guzmán Franch-Arcas; Alberto Gómez-Alonso
Journal:  Langenbecks Arch Surg       Date:  2012-11-06       Impact factor: 3.445

5.  Surgery for recurrent goitre: its complications and their risk factors.

Authors:  P E Müller; R Jakoby; G Heinert; F Spelsberg
Journal:  Eur J Surg       Date:  2001-11

6.  The recurrent laryngeal nerve related to thyroid surgery.

Authors:  G Sturniolo; C D'Alia; A Tonante; E Gagliano; F Taranto; M G Lo Schiavo
Journal:  Am J Surg       Date:  1999-06       Impact factor: 2.565

Review 7.  Total thyroidectomy for management of thyroid disease.

Authors:  I R Gough; D Wilkinson
Journal:  World J Surg       Date:  2000-08       Impact factor: 3.352

8.  Effect of hospital volume of thyroidectomies on outcomes following substernal thyroidectomy.

Authors:  Fredric M Pieracci; Thomas J Fahey
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

9.  Reoperative surgery for thyroid disease.

Authors:  Jérémie H Lefevre; Christophe Tresallet; Laurence Leenhardt; Christelle Jublanc; Jean-Paul Chigot; Fabrice Menegaux
Journal:  Langenbecks Arch Surg       Date:  2007-06-26       Impact factor: 3.445

10.  Can total thyroidectomy be performed as safely by general surgeons in provincial centers as by surgeons in specialized endocrine surgical units? Making the case for surgical training.

Authors:  T S Reeve; A Curtin; L Fingleton; P Kennedy; W Mackie; T Porter; D Simons; D Townend; L Delbridge
Journal:  Arch Surg       Date:  1994-08
View more
  6 in total

1.  Analysis of the Istanbul Forensic Medicine Institute expert decisions on recurrent laryngeal nerve injuries due to thyroidectomy between 2008-2012.

Authors:  M Arif Karakaya; Okay Koç; Feza Ekiz; A Feran Ağaçhan; Nuri Emrah Göret
Journal:  Ulus Cerrahi Derg       Date:  2015-06-24

2.  Remote-access hemithyroidectomy in a patient with papillary thyroid cancer after ipsilateral irradiation: a case report.

Authors:  Keiso Ho; Yoshiyuki Saito; Yoshifumi Ikeda; Hiroshi Takami; Toshiki Tokuda; Ryohei Miyata; Masato Tomita; Michio Sato; Nobutoshi Ando
Journal:  Gland Surg       Date:  2022-03

3.  The preoperative evaluation prevent the postoperative complications of thyroidectomy.

Authors:  Chien-Feng Huang; Yachung Jeng; Kuo-Dong Chen; Ji-Kuen Yu; Chao-Ming Shih; Shih-Ming Huang; Chen-Hsen Lee; Fong-Fu Chou; Ming-Lang Shih; Kee-Ching Jeng; Tzu-Ming Chang
Journal:  Ann Med Surg (Lond)       Date:  2014-12-18

4.  Preoperative risk factors in total thyroidectomy of substernal goiter.

Authors:  Aldo Bove; Raffaella Maria Di Renzo; Gauro D'Urbano; Manuela Bellobono; Vincenzo D'Addetta; Alfonso Lapergola; Giuseppe Bongarzoni
Journal:  Ther Clin Risk Manag       Date:  2016-11-28       Impact factor: 2.423

5.  Effects of Central Neck Dissection on Complications in Differentiated Thyroid Cancer.

Authors:  Mehmet Taner Unlu; Nurcihan Aygun; Zeynep Gul Demircioglu; Adnan Isgor; Mehmet Uludag
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-09-24

6.  To explore the risk factors and preventive measures affecting the treatment of retrosternal goiter: An observational study.

Authors:  Wei Li; Huisheng Li; Shanling Zhang; Yingjie Tao; Xudong Wang; Junping Cheng
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.